HIV-1 Capsid Uncoating Is a Multistep Process That Proceeds through Defect Formation Followed by Disassembly of the Capsid Lattice

被引:7
作者
Gifford, Levi B. [1 ]
Melikyan, Gregory B. [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA
关键词
HIV-1; capsid; single virus tracking; geneticcode expansion; click labeling; dynamics of capsid uncoating; nuclear import; COMPLEMENTARY ASSAYS REVEAL; GAG PROTEIN; SAMHD1; REPLICATION; RECOGNITION; STABILITY; INFECTION; STEPS; CCR5;
D O I
10.1021/acsnano.3c07678
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The HIV-1 core consists of a cone-shaped capsid shell made of capsid protein (CA) hexamers and pentamers encapsulating the viral genome. HIV-1 capsid disassembly, referred to as uncoating, is important for productive infection; however, the location, timing, and regulation of uncoating remain controversial. Here, we employ amber codon suppression to directly label CA. In addition, a fluid phase fluorescent probe is incorporated into the viral core to detect small defects in the capsid lattice. This double-labeling strategy enables the visualization of uncoating of single cores in vitro and in living cells, which we found to always proceed through at least two distinct steps the formation of a defect in the capsid lattice that initiates gradual loss of CA below a detectable level. Importantly, intact cores containing the fluid phase and CA fluorescent markers enter and uncoat in the nucleus, as evidenced by a sequential loss of both markers, prior to establishing productive infection. This two-step uncoating process is observed in different cells, including a macrophage line. Notably, the lag between the release of fluid phase marker and terminal loss of CA appears to be independent of the cell type or reverse transcription and is much longer (>5-fold) for nuclear capsids compared to cell-free cores or cores in the cytosol, suggesting that the capsid lattice is stabilized by capsid-binding nuclear factors. Our results imply that intact HIV-1 cores enter the cell nucleus and that uncoating is initiated through a localized defect in the capsid lattice prior to a global loss of CA.
引用
收藏
页码:2928 / 2947
页数:20
相关论文
共 97 条
  • [51] Fluorescence Microscopy Assay to Measure HIV-1 Capsid Uncoating Kinetics in vitro
    Marquez, Chantal L.
    Lau, Derrick
    Walsh, James
    Faysal, K. M. Rifat
    Parker, Michael W.
    Turville, Stuart G.
    Bocking, Till
    [J]. BIO-PROTOCOL, 2019, 9 (13):
  • [52] Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis
    Marquez, Chantal L.
    Lau, Derrick
    Walsh, James
    Shah, Vaibhav
    McGuinness, Conall
    Wong, Andrew
    Aggarwal, Anupriya
    Parker, Michael W.
    Jacques, David A.
    Turville, Stuart
    Bocking, Till
    [J]. ELIFE, 2018, 7
  • [53] Rotten to the core: antivirals targeting the HIV-1 capsid core
    McFadden, William M.
    Snyder, Alexa A.
    Kirby, Karen A.
    Tedbury, Philip R.
    Raj, Monika
    Wang, Zhengqiang
    Sarafianos, Stefan G.
    [J]. RETROVIROLOGY, 2021, 18 (01)
  • [54] LEDGF Dominant Interference Proteins Demonstrate Prenuclear Exposure of HIV-1 Integrase and Synergize with LEDGF Depletion To Destroy Viral Infectivity
    Meehan, Anne M.
    Saenz, Dyana T.
    Morrison, James
    Hu, Chunling
    Peretz, Mary
    Poeschla, Eric M.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (07) : 3570 - 3583
  • [55] Mörner A, 1999, J VIROL, V73, P2343
  • [56] Nuclear Capsid Uncoating and Reverse Transcription of HIV-1
    Mueller, Thorsten G.
    Zila, Vojtech
    Muller, Barbara
    Kraeusslich, Hans-Georg
    [J]. ANNUAL REVIEW OF VIROLOGY, 2022, 9 : 261 - 284
  • [57] HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells
    Mueller, Thorsten G.
    Zila, Vojtech
    Peters, Kyra
    Schifferdecker, Sandra
    Stanic, Mia
    Lucic, Bojana
    Laketa, Vibor
    Lusic, Marina
    Mueller, Barbara
    Kraeusslich, Hans-Georg
    [J]. ELIFE, 2021, 10
  • [58] Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative
    Müller, B
    Daecke, J
    Fackler, OT
    Dittmar, MT
    Zentgraf, H
    Kräusslich, HG
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (19) : 10803 - 10813
  • [59] Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components
    Neagu, Martha R.
    Ziegler, Patrick
    Pertel, Thomas
    Strambio-De-Castillia, Caterina
    Gruetter, Christian
    Martinetti, Gladys
    Mazzucchelli, Luca
    Gruetter, Markus
    Manz, Markus G.
    Luban, Jeremy
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) : 3035 - 3047
  • [60] HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins
    Park, Soyeong
    Auyeung, Andrew
    Lee, Denis L.
    Lambert, Paul F.
    Carchman, Evie H.
    Sherer, Nathan M.
    [J]. CANCERS, 2021, 13 (05) : 1 - 17